双鹭药业：目前公司短效促卵泡激素正在进行补充研究

Group 1 - The company, Shuanglu Pharmaceutical, is currently conducting supplementary research on its short-acting follicle-stimulating hormone (FSH) and plans to reapply for approval after the research is completed [1] - The long-acting recombinant human follicle-stimulating hormone (FSH-CTP) has already submitted its application for market approval [1]